Evaluation of a mosaic HIV-1 vaccine in a multicentre, randomised, double-blind, placebo-controlled, phase 1/2a clinical trial (APPROACH) and in rhesus monkeys (NHP 13-19)Dan H. Barouch, Ludo Lavreys, Juliet Mpendo et al.|The Lancet|2018Cited by 342
Final Analysis of Efficacy and Safety of Single-Dose Ad26.COV2.SJerald Sadoff, Macaya Douoguih, John J. Treanor et al.|New England Journal of Medicine|2022Cited by 250
Mosaic HIV-1 vaccine regimen in southern African women (Imbokodo/HVTN 705/HPX2008): a randomised, double-blind, placebo-controlled, phase 2b trialGlenda Gray, Mookho Malahleha, Azwidihwi Takalani et al.|The Lancet Infectious Diseases|2024Cited by 40